The Role of Maresin1 and Maresin2 Serum Levels in Prediction of Prognosis in Thrombectomised ischemic Stroke Patients
Dicle Tıp Dergisi · 05.06.2026 · 53 (2) · 331-341
DOI: 10.5798/dicletip.1964317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dicle Tıp Dergisi, online erschienen am 05.06.2026. Verfasst von Muttalip Özbek und 5 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Objective
Although endovascular treatment (EVT) is widely accepted as the standard approach for acute ischemic stroke (IS), the prognostic determinants are not yet fully clarified. This study was designed to investigate the prognostic value of serum Maresin-1 (MaR1) and Maresin-2 (MaR2) levels in IS patients treated with EVT.
Method
In this prospective study at Dicle University Faculty of Medicine, Department of Neurology, Stroke Center, 59 IS patients undergoing EVT and 24 healthy controls were enrolled between March 1 and August 1, 2024. Serum levels of MaR1, MaR2, albumin, hemoglobin A1C, neutrophils, platelets, lipid profile, vitamin D, C-reactive protein, and ferritin were measured. Clinical data included baseline NIHSS, 3-month mRS, TICI recanalization, and pre-stroke comorbidities. Multivariable logistic regression analyses were performed to evaluate associations between MaR1, MaR2, stroke severity, and mortality.
Results
MaR1 and MaR2 concentrations were markedly reduced in the ischemic stroke group compared with healthy controls (p = 0.04 and p = 0.02). In parsimonious multivariable logistic regression analyses for 3-month mortality, neither MaR1 nor MaR2 showed an independent association, although both demonstrated borderline relationships after adjustment for age and baseline NIHSS. In contrast, stroke severity analysis revealed that higher MaR1 levels were independently associated with increased stroke severity (OR = 2.123; 95% CI, 1.18–3.25; p = 0.047), whereas MaR2 was not. Additionally, lower serum albumin levels emerged as an independent predictor of greater stroke severity in both models.
Conclusions
These findings suggest that MaR1 may reflect stroke severity rather than mortality, while albumin represents a key systemic determinant of disease severity. Maresins appear to act as inflammation-related biomarkers whose prognostic effects are modulated by overall metabolic and inflammatory status.
Zitieren
APA
Özbek, M., Demir, F., Durmaz, C., Gültekin, H., Erkan, R. E. C., & Akıl, E. (2026). The Role of Maresin1 and Maresin2 Serum Levels in Prediction of Prognosis in Thrombectomised ischemic Stroke Patients. Dicle Tıp Dergisi, 53(2), 331-341. https://doi.org/10.5798/dicletip.1964317
Vancouver
Özbek M, Demir F, Durmaz C, Gültekin H, Erkan REC, Akıl E. The Role of Maresin1 and Maresin2 Serum Levels in Prediction of Prognosis in Thrombectomised ischemic Stroke Patients. Dicle Tıp Dergisi. 2026;53(2):331-341. doi:10.5798/dicletip.1964317
BibTeX
@article{zbek2026,
author = {Özbek, Muttalip and Demir, Fidel and Durmaz, Cebrail and Gültekin, Hamza and Erkan, Revşa Evin Canpolat and Akıl, Eşref},
title = {The Role of Maresin1 and Maresin2 Serum Levels in Prediction of Prognosis in Thrombectomised ischemic Stroke Patients},
journal = {Dicle Tıp Dergisi},
year = {2026},
volume = {53},
number = {2},
pages = {331--341},
doi = {10.5798/dicletip.1964317}
}
EUVIMED